theconnectionsnj.com PAGE 56 DINING OUT HEALTH & WELLNESS 3322 Route 22 West, Suite 1207-1208, Branchburg, NJ 08876 908- 218- 0300 908-218-0301 (fax) www.branchburgoralsurgery.com We Accept Most Major PPO Dental Plans Karl Maloney, D.D.S. Board Certified Oral & Maxillofacial Surgeon Wisdom Teeth Dental Implants Bone Grafting General Anesthesia 3D Cone Beam CT Oral Pathology Facial Trauma Restore Your Natural Beauty COSMETIC EYELID ENHANCEMENTS BOTOX JUVEDERM RESTYLANE RECONSTRUCTIVE EYELID SURGERY SUSAN R. CARTER, M.D. Director of Ophthalmic Plastic and Reconstructive Surgery Diplomat American Board of Ophthalmology Fellow American Society Ophthalmic Plastic & Reconstructive Surgeons Former Professor at the University of California at San Francisco With over 15 years of cosmetic and reconstructive experience 65 Mountain Blvd. Ext. Warren, NJ 07059 In the Warren Medical Center Across from the ACME CALL FOR YOUR CONSULTATION TODAY (732) 356-6200 www.The-Eye-Center.com any mental health concerns such as depression and other mental health conditions are affecting a large number of individuals in society today. Depression affects roughly 21 million Americans and about 280 million individuals worldwide. About a third of these individuals would meet the criteria for treatment-resistant depression. The medical profession is starting to prioritize these conditions and offering patients options for treatment of the various conditions that affect them. The Johnson and Johnson pharmaceutical company has developed a medication called Esketamine. Esketamine is administered in a spray that is called Spravato. Spravato is FDA-approved to treat depression. The current theory is that Spravato treats depression by blocking receptors in the brain which are classified as N-methyl-D-aspartate or NMDA receptors. Blocking these receptors causes the release of glutamate, which is a regulatory neurotransmitter that can affect mood. This treatment has been known to have some side effects such as nausea, dizziness, sedation, dissociation, and an increase in blood pressure. Therefore, it should only be administered in a medical office with monitoring and under the supervision of a psychiatrist or physician. Spravato has been shown to be effective in treating individuals with treatment-resistant depression. Although it was initially recommended that Esketamine be used together with other antidepressant medications, the FDA has recently approved the Esketamine nasal spray Spravato to be used as a monotherapy or by itself for treatment-resistant depression. If you haven’t found something that works for you yet, maybe a call to Providence Medical & Infusion Center might be the answer. Sit with one of their doctors to determine the best plan for you. For any further questions regarding Spravato or related to any treatment of treatment-resistant depression, call Providence Medical & Infusion Providence Medical & Infusion Center today. Providence Medical & Infusion Center 571 Central Ave., Suite 104A New Providence, NJ 855.535.1252 providencemedandinfusion.com MEDICAL MINUTES Treatment-Resistant Depression Treated By Dr. Nalin Ranasinghe & Dr. Ritesh Amin M any mental health con Dr. Ritesh Amin Dr. Nalin Ranasinghe
RkJQdWJsaXNoZXIy NzA2NDY0